Skip to main contentAI and Advanced
/
MEDANTA · NSEBSE SENSEX77,537.72+0.82%BSE |
NIFTY 5024,231.85+0.64%NSE |
NIFTY BANK57,495.9+0.45%NSE |
NIFTY IT30,673.05+0.79%NSE |
NIFTY AUTO29,301.75+0.40%NSE |
NIFTY FMCG47,863.25+0.82%NSE |
NIFTY PHARMA26,416+0.39%NSE |
NIFTY 50023,512.95+0.54%NSE |
ME
NSE · Equity shares · Healthcare Facilities-19.00 · -1.33%
Global Health MEDANTA
NSE:INR 1,410
BSE:INR 1,440.1
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for MEDANTA
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 1,429
Day rangeINR 1,401 — INR 1,429.6
52-week rangeINR 956 — INR 1,491
Volume1.21 L
Market cap38,871.79
P/E63.47
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)4,410.27
Net Income (INR Cr)556.46
Rev Growth (5 Year %)24.97
EPS Growth (5 Year %)80.64
P/E Ratio63.47
EPS20.69
Research path: Interpret Global Health's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
MEDANTAGlobal Health1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 5,905 | 4,766.23 | 4,304.08 |
| Cash Equivalents | 127.33 | 148.17 | 310.53 |
| Other Liabilities Total | 166.54 | 136.4 | 126.61 |
| Long Term Debt | 601.12 | 264.1 | 283.47 |
| Common Stock Total | 53.74 | 53.72 | 53.7 |
| Other Current Assets Total | 22.37 | 1.68 | 4.21 |
| Total Assets | 5,905 | 4,766.23 | 4,304.08 |
| Current Portof LT Debt/Capital Leases | 62.99 | 94.23 | 171.89 |
| Total Equity | 3,961.57 | 3,386.41 | 2,905.63 |
| Long Term Investments | 114.24 | 20.57 | 16.09 |
| Retained Earnings(Accumulated Deficit) | 3,907.83 | 2,260.66 | 1,784.03 |
| Total Common Shares Outstanding | 26.86 | 26.86 | 26.85 |
| Tangible Book Valueper Share Common Eq | 146.87 | 125.66 | 108.01 |
| Total Liabilities | 1,943.43 | 1,379.82 | 1,398.45 |
| Total Debt | 1,190.05 | 717.73 | 801.87 |
| Short Term Investments | 1,035.05 | 892.14 | 750.68 |
| Cashand Short Term Investments | 1,162.39 | 1,122.34 | 1,175.28 |
| Total Receivables Net | 411.19 | 324.23 | 247.01 |
| Accounts Receivable-Trade Net | 411.19 | 314.65 | 236.12 |
| Property/Plant/Equipment Total-Net | 3,910.92 | 3,036.06 | 2,617.9 |
| Minority Interest | 22.71 | 1.1 | -0.03 |
| Total Current Liabilities | 627.13 | 618.82 | 617.73 |
| Total Inventory | 78.98 | 69.28 | 74.45 |
| Accounts Payable | 242.37 | 194.81 | 186.78 |
| Other Currentliabilities Total | 321.77 | 270.66 | 184.55 |
| Total Long Term Debt | 1,127.06 | 623.51 | 629.98 |
| Intangibles Net | 16.2 | 11.29 | 5.54 |
| Other Long Term Assets Total | 133.25 | 57.5 | 74.09 |
| Note Receivable-Long Term | 55.48 | 107.7 | 81.73 |
| Total Current Assets | 1,674.92 | 1,533.12 | 1,508.73 |
| Capital Lease Obligations | 525.94 | 359.41 | 346.52 |
| Accumulated Depreciation Total | Not available | -1,050.13 | -979.02 |
| Accrued Expenses | Not available | 59.12 | 74.52 |
| Prepaid Expenses | Not available | 15.6 | 7.78 |
| Additional Paid-In Capital | Not available | 1,072.03 | 1,067.9 |
| Cash | Not available | 82.03 | 114.08 |
| Property/Plant/Equipment Total-Gross | Not available | 4,086.19 | 3,210.65 |
| Notes Payable/Short Term Debt | Not available | 0 | 0 |
| Deferred Income Tax | Not available | 0 | 24.16 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio3.78
Price to Sale Ratio8.81
Growth
Debt 5Yr CAGR %5.02
Margins
Operating Margin 12m15.2
Operating Margin 5y Avg17.09
Net Profit Margin 12m11.79
Net Profit Margin 5y12.54
Yield
Dividend Yield %0.04
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk27.8
Analyst consensus
ConsensusBuy
Consensus score2.18
Analyst opinions11
Strong Sell count0
Sell count1
Hold count4
Buy count2
Strong Buy count4
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 64.93 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 71.47 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.89 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 33.00%
- FII
- 9.46%
- MF
- 16.03%
- Other
- 41.51%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Global Health Limited (ASX:GLH): Could This Healthcare Technology Company Be Gaining Momentum? - KalkineMarket news · 10 Jul 2026, 7:27 am
Global Health Limited (ASX:GLH): Could This Healthcare Technology Company Be Gaining Momentum? Kalkine
Price to earnings forward of Global Health Limited – NSE:MEDANTA - TradingViewMarket news · 9 Jul 2026, 9:57 am
Price to earnings forward of Global Health Limited – NSE:MEDANTA TradingView
Enterprise value to revenue forward of Global Health Limited – NSE:MEDANTA - TradingViewMarket news · 9 Jul 2026, 2:13 am
Enterprise value to revenue forward of Global Health Limited – NSE:MEDANTA TradingView
Price to book forward of Global Health Limited – BSE:MEDANTA - TradingViewMarket news · 8 Jul 2026, 2:00 pm
Price to book forward of Global Health Limited – BSE:MEDANTA TradingView
Hantavirus Cruise Outbreak Declared Over, Risk Was Limited - thetraveler.orgMarket news · 3 Jul 2026, 4:36 pm
Hantavirus Cruise Outbreak Declared Over, Risk Was Limited thetraveler.org
Ashima Ltd is Rated Strong Sell - MarketsMojoMarket news · 3 Jul 2026, 11:07 am
Ashima Ltd is Rated Strong Sell MarketsMojo
Corporate actions
Events
- dividendRs.0.5000 per share(25%)Final Dividend
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- dividendRs.0.5000 per share(25%)Final Dividend
ShareKeyX Community
Discussion and sentiment for Global Health
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. Medanta provides healthcare services in over 30 medical specialties and engages over 1,800 doctors. Its specialty treatments are in cardiac care, cancer care, neurosciences, orthopedics, renal care, liver transplants, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, ENT, head and neck surgery, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, homecare services, health checkups, elder care, air ambulance, among others. Its subsidiaries include Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- MEDANTA
- BSE Code
- 543654
Questions
Stock FAQ
What is the symbol and ISIN of Global Health?
Global Health has the symbol MEDANTA and ISIN - INE474Q01031.
What is the current price of Global Health?
Global Health is currently trading at INR 1,410.00.
What are the year high and year low of Global Health?
Global Health has a year high of INR 1,491.00 and a year low of INR 956.00.
What is the market capitalization of Global Health?
Global Health has a market capitalization of INR 38,871.79 crore.
What is the P/E ratio of Global Health?
Global Health has a P/E ratio of 63.47.
What is the dividend yield of Global Health?
Global Health has a dividend yield of 0.04%.
How is the financial performance of Global Health based on revenue, net income, and EPS?
Global Health has revenue of INR 4,410.27 crore, net income of INR 556.46 crore, and EPS of INR 21.29.
What is the book value of Global Health?
Global Health has a book value of NA.
What is the debt-to-equity ratio of Global Health?
Global Health has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Global Health?
Global Health has a price-to-book ratio of NA and a price-to-sales ratio of 8.81.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.